Nationally, about 36,000 new breast cancers cases are diagnosed annually in women under age 50 ??“ more than the total number of cervical and ovarian cancers combined. Breast cancer is the leading cause of death in American women ages 15-54.

Improved detection methods plus risk-assessment tools such as the HALO Breast Pap Test provide powerful new ways to enhance breast health. There are now established methods for reducing the threat of breast cancer in women identified as higher-risk. But before the development of HALO, there was no method for conveniently identifying patients who could benefit from these preventative regimens.

HALO is a low-cost, 5-minute, noninvasive test that helps determine an individual woman's risk of developing breast cancer, allowing women at increased risk to take risk reduction measures and be screened more frequently with methods that are more effective at detecting small, early-stage tumors.

neomatrix/